This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Hims and Hers Health surpassed third-quarter revenue expectations, driven by subscriber growth and expanded personalized ...

Shares of Hims & Hers Health ($HIMS) rallied in pre-market hours on Tuesday after management said it’s in discussions with ...

IF you’ve ever searched for weight loss tips online, you will know the deep rabbit hole that awaits. But now, social media ...

Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...

Get key Q3 2025 earnings insights for Hims & Hers Health (HIMS): revenue growth, new partnerships, and global expansion plans.

Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera ...

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Live Updates Live Coverage Updates appear automatically as they are published. Get The Best Hims & Hers Live Earnings ...

Nestlé is embracing the GLP-1 revolution with new weight management innovations, academic partnerships, and products tailored to users of drugs like Wegovy and Ozempic. Discover how the food industry ...